704 related articles for article (PubMed ID: 19812353)
1. Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors.
Zhong B; Wang DH
Am J Physiol Regul Integr Comp Physiol; 2009 Dec; 297(6):R1681-90. PubMed ID: 19812353
[TBL] [Abstract][Full Text] [Related]
2. N-oleoyldopamine, a novel endogenous capsaicin-like lipid, protects the heart against ischemia-reperfusion injury via activation of TRPV1.
Zhong B; Wang DH
Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H728-35. PubMed ID: 18567714
[TBL] [Abstract][Full Text] [Related]
3. TRPV1 gene knockout impairs preconditioning protection against myocardial injury in isolated perfused hearts in mice.
Zhong B; Wang DH
Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1791-8. PubMed ID: 17586621
[TBL] [Abstract][Full Text] [Related]
4. TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice.
Wang L; Wang DH
Circulation; 2005 Dec; 112(23):3617-23. PubMed ID: 16314376
[TBL] [Abstract][Full Text] [Related]
5. Protease-activated receptor 2 protects against myocardial ischemia-reperfusion injury through the lipoxygenase pathway and TRPV1 channels.
Zhong B; Ma S; Wang DH
Exp Ther Med; 2019 Nov; 18(5):3636-3642. PubMed ID: 31602241
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotection by ischemic postconditioning is lost in isolated perfused heart from diabetic rats: Involvement of transient receptor potential vanilloid 1, calcitonin gene-related peptide and substance P.
Ren JY; Song JX; Lu MY; Chen H
Regul Pept; 2011 Aug; 169(1-3):49-57. PubMed ID: 21554904
[TBL] [Abstract][Full Text] [Related]
7. Exploring the putative role of TRPV
Randhawa PK; Jaggi AS
Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28599085
[TBL] [Abstract][Full Text] [Related]
8. Interdependent regulation of afferent renal nerve activity and renal function: role of transient receptor potential vanilloid type 1, neurokinin 1, and calcitonin gene-related peptide receptors.
Xie C; Sachs JR; Wang DH
J Pharmacol Exp Ther; 2008 Jun; 325(3):751-7. PubMed ID: 18364471
[TBL] [Abstract][Full Text] [Related]
9. Protective Effects of TRPV1 Activation Against Cardiac Ischemia/ Reperfusion Injury is Blunted by Diet-Induced Obesity.
Zhong B; Ma S; Wang DH
Cardiovasc Hematol Disord Drug Targets; 2020; 20(2):122-130. PubMed ID: 31513001
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Role of TRPV and CGRP in Adenosine Preconditioning and Remote Hind Limb Preconditioning-Induced Cardioprotection in Rats.
Singh A; Randhawa PK; Bali A; Singh N; Jaggi AS
Cardiovasc Drugs Ther; 2017 Apr; 31(2):133-143. PubMed ID: 28194544
[TBL] [Abstract][Full Text] [Related]
11. Investigating the involvement of TRPV
Randhawa PK; Jaggi AS
Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):117-126. PubMed ID: 27752734
[TBL] [Abstract][Full Text] [Related]
12. Transient Receptor Potential Vanilloid Subtype 1 Inhibits Inflammation and Apoptosis via the Release of Calcitonin Gene-Related Peptide in the Heart after Myocardial Infarction.
Lei J; Zhu F; Zhang Y; Duan L; Lei H; Huang W
Cardiology; 2016; 134(4):436-43. PubMed ID: 27144592
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of transient receptor potential vanilloid 1 impaires the postischemic recovery of diabetic mouse hearts.
Wei Z; Wang L; Han J; Song J; Yao L; Shao L; Sun Z; Zheng L
Circ J; 2009 Jun; 73(6):1127-32. PubMed ID: 19372621
[TBL] [Abstract][Full Text] [Related]
14. Role of B-type natriuretic peptide in epoxyeicosatrienoic acid-mediated improved post-ischaemic recovery of heart contractile function.
Chaudhary KR; Batchu SN; Das D; Suresh MR; Falck JR; Graves JP; Zeldin DC; Seubert JM
Cardiovasc Res; 2009 Jul; 83(2):362-70. PubMed ID: 19401302
[TBL] [Abstract][Full Text] [Related]
15. Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia.
Amadesi S; Nie J; Vergnolle N; Cottrell GS; Grady EF; Trevisani M; Manni C; Geppetti P; McRoberts JA; Ennes H; Davis JB; Mayer EA; Bunnett NW
J Neurosci; 2004 May; 24(18):4300-12. PubMed ID: 15128844
[TBL] [Abstract][Full Text] [Related]
16. TRPV1 activation exacerbates hypoxia/reoxygenation-induced apoptosis in H9C2 cells via calcium overload and mitochondrial dysfunction.
Sun Z; Han J; Zhao W; Zhang Y; Wang S; Ye L; Liu T; Zheng L
Int J Mol Sci; 2014 Oct; 15(10):18362-80. PubMed ID: 25314299
[TBL] [Abstract][Full Text] [Related]
17. SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
Strande JL; Hsu A; Su J; Fu X; Gross GJ; Baker JE
Basic Res Cardiol; 2007 Jul; 102(4):350-8. PubMed ID: 17468933
[TBL] [Abstract][Full Text] [Related]
18. The cardioprotection of rutaecarpine is mediated by endogenous calcitonin related-gene peptide through activation of vanilloid receptors in guinea-pig hearts.
Hu CP; Xiao L; Deng HW; Li YJ
Planta Med; 2002 Aug; 68(8):705-9. PubMed ID: 12221592
[TBL] [Abstract][Full Text] [Related]
19. 12-Lipoxygenase-derived eicosanoids protect against myocardial ischemia/reperfusion injury via activation of neuronal TRPV1.
Sexton A; McDonald M; Cayla C; Thiemermann C; Ahluwalia A
FASEB J; 2007 Sep; 21(11):2695-703. PubMed ID: 17470568
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
